🇺🇸 lidocaine and prilocaine in United States

FDA authorised lidocaine and prilocaine on 18 August 2003

Marketing authorisations

FDA — authorised 18 August 2003

  • Application: ANDA076453
  • Marketing authorisation holder: FOUGERA PHARMS
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 27 August 2003

  • Application: ANDA076320
  • Marketing authorisation holder: ENCUBE
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 25 September 2003

  • Application: ANDA076290
  • Marketing authorisation holder: HIKMA
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 29 June 2018

  • Application: ANDA205887
  • Marketing authorisation holder: PAI HOLDINGS PHARM
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 21 September 2020

  • Application: ANDA213253
  • Marketing authorisation holder: CHARTWELL RX
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 27 July 2021

  • Application: ANDA212482
  • Marketing authorisation holder: PADAGIS US
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 8 April 2022

  • Application: ANDA213923
  • Marketing authorisation holder: ALEMBIC
  • Local brand name: LIDOCAINE AND PRILOCAINE
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 17 December 2024

  • Application: ANDA219120
  • Marketing authorisation holder: ZYDUS LIFESCIENCES
  • Status: approved

FDA

  • Status: approved

lidocaine and prilocaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is lidocaine and prilocaine approved in United States?

Yes. FDA authorised it on 18 August 2003; FDA authorised it on 27 August 2003; FDA authorised it on 25 September 2003.

Who is the marketing authorisation holder for lidocaine and prilocaine in United States?

FOUGERA PHARMS holds the US marketing authorisation.